Key Points
- Intuitive Surgical SVP Iman Jeddi sold 5,625 shares on June 1 at an average price of $420.55, totaling about $2.37 million. After the pre-arranged Rule 10b5-1 sale, Jeddi’s stake fell by 46.53% to 6,463 shares.
- Shares of ISRG have been under pressure, with the stock opening at $402.30 and trading near its 52-week low of $396.68. The company’s 50-day and 200-day moving averages are also well above the current price, suggesting recent weakness.
- Analyst sentiment is mixed but leans positive overall: Deutsche Bank cut its price target to $366 and kept a sell rating, while other firms such as Baird and Barclays maintained bullish targets. Despite the pullback, Intuitive Surgical beat quarterly earnings and revenue estimates last quarter.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Iman Jeddi sold 5,625 shares of the business's stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares of the company's stock, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $402.30 on Wednesday. The firm has a market cap of $142.48 billion, a price-to-earnings ratio of 48.76, a PEG ratio of 3.29 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88. The firm has a 50 day moving average price of $452.19 and a 200-day moving average price of $504.81.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts' consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business's quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.81 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.
Key Stories Impacting Intuitive Surgical
Here are the key news stories impacting Intuitive Surgical this week:
- Negative Sentiment: Deutsche Bank cut its price target on Intuitive Surgical (ISRG) to $366 from $440 and kept a sell rating, reinforcing concerns that the stock may have further downside from current levels. MarketScreener article
- Negative Sentiment: Company SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 plan, a transaction that can still weigh on sentiment because it reduces insider ownership and may signal caution to some investors.
- Neutral Sentiment: Several articles highlighted that ISRG is a highly watched and frequently traded name, but these pieces were mostly informational and did not present a new catalyst. Zacks article
- Neutral Sentiment: Analysts and commentary also pointed to Intuitive Surgical’s AI-driven digital roadmap and connected da Vinci ecosystem as a potential long-term growth driver, but that story appears to be offset today by valuation and rating concerns. Yahoo Finance article
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Holos Integrated Wealth LLC bought a new position in Intuitive Surgical in the 4th quarter worth $25,000. Newbridge Financial Services Group Inc. raised its holdings in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. bought a new position in Intuitive Surgical in the 3rd quarter worth $27,000. Olistico Wealth LLC bought a new position in Intuitive Surgical in the 4th quarter worth $28,000. Finally, Caitlin John LLC bought a new position in Intuitive Surgical in the 3rd quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on ISRG shares. Robert W. Baird upped their price target on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an "outperform" rating in a report on Wednesday, April 22nd. Barclays set a $651.00 price target on shares of Intuitive Surgical and gave the company an "overweight" rating in a report on Thursday, April 23rd. UBS Group lowered their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a "neutral" rating for the company in a report on Tuesday, March 17th. Weiss Ratings reiterated a "hold (c)" rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Finally, Truist Financial lowered their price target on shares of Intuitive Surgical from $650.00 to $580.00 and set a "buy" rating for the company in a report on Wednesday, April 15th. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus price target of $573.63.
Get Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
